Heres what researchers have learned recently about neurokinin B and hot flashes: Neurokinin B was identified in a genome-wide association study as the only gene that plays a significant role in hot flashes (vasomotor symptoms).[ref] Another strong indication that neurokinin B is integral to hot flashes is that when neurokinin B is given to young women by IV, it triggers hot flashes in 80% of the women.[ref] A placebo-controlled clinical trial of an NK3R (neurokinin B receptor) antagonist drug, which blocks the neurokinin B receptor, showed that it quickly reduced hot flash frequency by more than half compared to a placebo.[ref][ref] The emerging picture is that hot flashes involve body temperature mechanisms in the hypothalamus that are affected by estrogen and neurokinin B, which in turn affect FSH and LH levels

Hyperpigmentation was observed when this compound got oxidized and inactivated by factors such as heat, radiation and inflammation with consequent loss of the inhibitory effect on tyrosinase
This includes appropriate personal protective equipment, clean preparation surfaces, labelled containers, controlled disposal, and accurate record keeping
10.1155/2015/287401 Biomed Res Int
In animals studies, BPC-157 has been administered in the following ways: To rats at a dose of 10 mcg/kg via injection [12] To mice at a dose of 10 g or 10 ng/kg body weight intraperitoneally (i.p.) via injection [14] To mice as a thin layer of cream topically (50 g of BPC 157 dissolved in 2 ml of distilled water with 50 g of commercial neutral cream and 1% white silver sulfadiazine)
Biochem Biophys Res Commun 397:608613 Yang M, Dong Y, He Q, Zhu P, Zhuang Q, Shen J, Zhang X, Zhao M (2020) Hydrogen: a novel option in human disease treatment